Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000774849 | SCV000908868 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-03-19 | criteria provided, single submitter | clinical testing | This variant deletes 1 nucleotide in exon 4 of the PALB2 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of PALB2 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. |
Baylor Genetics | RCV003472298 | SCV004202140 | likely pathogenic | Familial cancer of breast | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Genomic Center, |
RCV001293837 | SCV001481768 | pathogenic | Colorectal cancer | no assertion criteria provided | case-control |